Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US12/042,235external-prioritypatent/US8183253B2/en
Application filed by Натко Фарма ЛимитедfiledCriticalНатко Фарма Лимитед
Priority claimed from PCT/IB2009/005421external-prioritypatent/WO2009109867A2/en
Publication of UA103610C2publicationCriticalpatent/UA103610C2/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
The present invention relates to a particular form of the (3,5-bis trifluoromethyl)-N-[4-methyl-3-(4-pyridin-3yl-pyrirnidin-2ylamino)-phenyl]-benzamide (formula I), processes for the preparation thereof, pharmaceutical compositions containing this crystal form, and their use as anti tumor agent in humans. The compound of formula L, also known as AN-019, is:, (I)
UAA201010597A2008-03-042009-03-02Crystal form of phenylamino pyrimidine derivative
UA103610C2
(en)